Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of MetaCalm at Two Dose Levels in Healthy Adults With Acute Stress: An Open-Label, Non-Randomized Clinical Study

NCT07507669 is registered in ClinicalTrials.gov with Metagenics, Inc. as lead sponsor.

NCT NCT07507669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07507669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of MetaCalm at Two Dose Levels in Healthy Adults With Acute Stress: An Open-Label, Non-Randomized Clinical Study
Lead sponsor
Metagenics, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
April 15, 2026
Completion date
August 31, 2026
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stress reaction, adults